Hepatitis E virus infection in developed countries

被引:27
|
作者
Miyamura, Tatsuo [1 ]
机构
[1] Natl Inst Infect Dis, Shinjuku Ku, Tokyo 1628640, Japan
关键词
Hepatitis E; Hepatitis E virus; Faecal-oral transmission; Food-borne infection; Zoonosis; NON-B-HEPATITIS; TRANSMITTED NON-A; ELEVATED ALANINE AMINOTRANSFERASE; ORGAN-TRANSPLANT RECIPIENTS; JAPANESE BLOOD-DONORS; POSSIBLE RISK-FACTORS; LOCAL GROCERY STORES; BOARS SUS-SCROFA; PIG LIVERS SOLD; WILD BOAR;
D O I
10.1016/j.virusres.2011.03.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis E was considered to be endemic infectious disease in developing countries in tropical or subtropical regions with poor sanitary conditions. Large, previously reported outbreaks were mainly due to contaminated water or heavy flooding. Prototype hepatitis E viruses of genotypes I and II were obtained from such endemic cases. In developed countries, in contrast, hepatitis E was rare and diagnosed only in travelers or imported cases. However, the development of accurate diagnostic tests, mainly PCR detection elucidated that autochthonous hepatitis E in developed countries is far more common than previously thought. Although the main route of transmission is food-borne, other routes including blood-borne have been suggested. Recent developments of gene-based diagnostic assays and molecular epidemiology have disclosed the significance of hepatitis E virus infection in developed countries. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [41] Dual Infection of Hepatitis A Virus and Hepatitis E Virus- What Is Known?
    Sayed, Ibrahim M.
    [J]. VIRUSES-BASEL, 2023, 15 (02):
  • [42] Does infection with hepatitis A virus provide protection against hepatitis E virus?
    Syed, SA
    Sarwari, AR
    Smego, RA
    Hamid, S
    Nissa, T
    [J]. MEDICAL HYPOTHESES, 2003, 60 (03) : 337 - 339
  • [43] Molecular Biology and Infection of Hepatitis E Virus
    Nan, Yuchen
    Zhang, Yan-Jin
    [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [44] Hepatitis E virus infection: a paradigm shift?
    Pischke, S.
    Potthoff, A.
    Hauroeder, B.
    Schlue, J.
    Manns, M. P.
    Cornberg, M.
    Wedemeyer, H.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (22) : 1129 - 1133
  • [45] Current knowledge on Hepatitis E virus infection
    Pepovich, Roman
    Baymakova, Magdalena
    Pishmisheva, Maria
    Marutsov, Plamen
    Pekova, Liliya
    Tsachev, Ilia
    [J]. VOJNOSANITETSKI PREGLED, 2019, 76 (07) : 733 - 739
  • [46] Hepatitis E virus infection in equines in Spain
    Garcia-Bocanegra, Ignacio
    Rivero, Antonio
    Caballero-Gomez, Javier
    Lopez-Lopez, Pedro
    Cano-Terriza, David
    Frias, Mario
    Jimenez-Ruiz, Saul
    Risalde, Maria A.
    Gomez-Villamandos, Jose C.
    Rivero-Juarez, Antonio
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2019, 66 (01) : 66 - 71
  • [47] The molecular epidemiology of hepatitis E virus infection
    Purdy, Michael A.
    Khudyakov, Yury E.
    [J]. VIRUS RESEARCH, 2011, 161 (01) : 31 - 39
  • [48] Hepatitis E virus infection in cancer patients
    Chiu, C. Y.
    Zhang, H. C.
    Westin, J.
    Hosing, C.
    Torres, H.
    [J]. SWISS MEDICAL WEEKLY, 2022, 152 : 29S - 29S
  • [49] Hepatitis E virus infection and immunocompromised individuals
    Mallet, Vincent
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2017, 201 (4-6): : 649 - 655
  • [50] Ribavirin for Chronic Hepatitis E Virus Infection
    Harrabi, Hejer
    Maaloul, Imed
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (25): : 2446 - 2446